Concepedia

Publication | Closed Access

Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study

DOI

41

Citations

0

References

2018

Year

M. Baron, B. Peyronnet, A. Aublé, J. Hascoët, É. Castel-Lacanal, Gabriel Miget, Sabine Le Doze, Thomas Prudhomme, A. Manunta, Jean‐Nicolas Cornu,
The Journal of Urology

Abstract

More than half of the patients with neurogenic detrusor overactivity discontinued intradetrusor botulinum toxin A within the first 10 years after the initial injection. Patients with spina bifida are at high risk for discontinuation.